Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|October 2, 2025
Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancerQiuyue Su, Xiangdong Tian, Fucheng Li, et al.
Bioscience Trends|July 16, 2025
Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCABo Sun, Yimeng Wang, Ruyu Han, et al.
Cancer Biology & Medicine|May 24, 2019
Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastomaLu Chen, Xiangdong Tian, Wenchen Gong, et al.
Nature Communications|January 7, 2026
Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trialLu Chen, Shujie Zhai, Yayue Liu, et al.
Oncotarget|September 24, 2016
Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathwayWenchen Gong, Baocun Sun, Xiulan Zhao, et al.
Iscience|February 6, 2024
OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinomaYali Wang, Lin Shi, Yuchao He, et al.
Endocrine Pathology|December 3, 2019
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung AdenocarcinomasJianghua Wu, Yanhui Zhang, Tingting Ding, et al.
Cancer Gene Therapy|November 26, 2024
CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinomaPing Yue, Yuchao He, Ran Zuo, et al.
EMBO Molecular Medicine|September 2, 2025
5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinomaYuanying Feng, Yuchao He, Ran Zuo, et al.
Hepatology International|May 20, 2024
Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular-cholangiocarcinomaWenchen Gong, Su Zhang, Xiangdong Tian, et al.
Pageof 5